QQQ
+ 0.00
387.12
+ 0%
BTC/USD
-813.00
56371.07
-1.42%
DIA
+ 0.00
340.46
+ 0%
SPY
+ 0.04
450.46
+ 0.01%
TLT
+ 0.00
152.34
+ 0%
GLD
+ 0.05
166.11
+ 0.03%

Where Vertex Pharmaceuticals Stands With Analysts

September 7, 2021 1:46 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Where Vertex Pharmaceuticals Stands With Analysts

Vertex Pharmaceuticals (NASDAQ:VRTX) has observed the following analyst ratings within the last quarter:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 4 7 3 3 0
Last 30 Days 0 0 0 1 0
1 Month Ago 0 0 0 0 0
2 Months Ago 0 2 1 2 0
3 Months Ago 4 5 2 0 0

These 17 analysts have an average price target of $247.12 versus the current price of Vertex Pharmaceuticals at 193.725, implying upside.

Below is a summary of how these 17 analysts rated Vertex Pharmaceuticals over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the move negative analysts are on the stock

price target chart

This current average represents a 8.03% increase from the previous average price target of $268.69.

What Are Analyst Ratings?

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.

Posted-In:

Analyst Ratings

Related Articles

Expert Ratings For Vertex Pharmaceuticals

Expert Ratings For Vertex Pharmaceuticals

Over the past 3 months, 5 analysts have published their opinion on Vertex Pharmaceuticals (NASDAQ:VRTX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. read more
Expert Ratings For Vertex Pharmaceuticals

Expert Ratings For Vertex Pharmaceuticals

Vertex Pharmaceuticals (NASDAQ:VRTX) has observed the following analyst ratings within the last quarter: read more
Where Vertex Pharmaceuticals Stands With Analysts

Where Vertex Pharmaceuticals Stands With Analysts

Over the past 3 months, 16 analysts have published their opinion on Vertex Pharmaceuticals (NASDAQ:VRTX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. read more

Expert Ratings for Vertex Pharmaceuticals

Analysts have provided the following ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago read more